Advertisement
Australia markets close in 3 minutes

  • ALL ORDS

    8,032.70
    +20.60 (+0.26%)
     

  • ASX 200

    7,790.60
    +21.20 (+0.27%)
     

  • AUD/USD

    0.6665
    +0.0006 (+0.09%)
     

  • OIL

    82.34
    +0.17 (+0.21%)
     

  • GOLD

    2,378.30
    +9.30 (+0.39%)
     

  • Bitcoin AUD

    96,924.64
    -1,308.05 (-1.33%)
     

  • CMC Crypto 200

    1,353.33
    -7.00 (-0.51%)
     

  • AUD/EUR

    0.6215
    -0.0002 (-0.03%)
     

  • AUD/NZD

    1.0878
    +0.0005 (+0.04%)
     

  • NZX 50

    11,682.39
    -89.42 (-0.76%)
     

  • NASDAQ

    19,752.30
    -156.56 (-0.79%)
     

  • FTSE

    8,272.46
    +67.35 (+0.82%)
     

  • Dow Jones

    39,134.76
    +299.90 (+0.77%)
     

  • DAX

    18,254.18
    +186.27 (+1.03%)
     

  • Hang Seng

    18,072.53
    -262.79 (-1.43%)
     

  • NIKKEI 225

    38,583.24
    -49.78 (-0.13%)
     

Insider Sale at Crinetics Pharmaceuticals Inc (CRNX): Chief Scientific Officer Stephen Betz ...

GuruFocus Research
·1-min read

Chief Scientific Officer Stephen Betz of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) sold 3,000 shares of the company on June 10, 2024, according to a recent SEC Filing. Following this transaction, the insider now owns 83,643 shares of the company.

Crinetics Pharmaceuticals Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

The shares were sold at a price of $43.86 each, placing the total value of the transaction at approximately $131,580. The sale occurred at a time when the stock has a market cap of approximately $3.53 billion. The company's valuation metrics include a price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow.

ADVERTISEMENT

Over the past year, Stephen Betz has sold a total of 24,000 shares of Crinetics Pharmaceuticals Inc and has not made any purchases of the stock. The insider transaction history for the company shows a pattern of 25 insider sells and no insider buys over the last year.

Insider Sale at Crinetics Pharmaceuticals Inc (CRNX): Chief Scientific Officer Stephen Betz Sells Shares
Insider Sale at Crinetics Pharmaceuticals Inc (CRNX): Chief Scientific Officer Stephen Betz Sells Shares

For more detailed information on the valuation of Crinetics Pharmaceuticals Inc, interested parties can refer to the GF Value of the stock.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

This article first appeared on GuruFocus.